• Contact info@abtriva.com for inquiries and orders.
  • Chinese (Simplified)

  • English

  • German

  • Korean

  • Spanish

United States (English / $ USD)

Recombinant Human Sphingolipid delta (4)-desaturase/C4-hydroxylase DES2 (DEGS2), Truncated

ACP08165

Number
Order Exclusive Products Now

Request a Quote
High Purity LevelsPrecision and ReliabilityCustomization Options

Specifications


Cat.No ACP08165 Target NameDEGS2
Target SynonymsDEGS2; C14orf66; Sphingolipid delta(4-desaturase/C4-monooxygenase DES2; Degenerative spermatocyte homolog 2; Sphingolipid 4-desaturase; Sphingolipid C4-monooxygenaseFormLyophilized powder
Expression SystemCustom Production. Please inquire and provide the desire expression system.Protein LengthPartial
Purity>85% (SDS-PAGE)Storage Buffer5%-50% glycerol. Lyophilized powder form: the buffer before lyophilization is Tris/PBS-based buffer, 6% Trehalose, Liquid form: default storage buffer is Tris/PBS-based buffer, pH 8.0.

Immunogen Information


Target SpeciesHumanUniprot IDQ6QHC5
Background Information
  • Uniprot Id

    Q6QHC5

  • Target Species

    Human

  • Target Name

    DEGS2

  • Target Full Name

    Sphingolipid delta(4)-desaturase/C4-monooxygenase DES2

  • Target Function

    Bifunctional enzyme which acts as both a sphingolipid delta(4)-desaturase and a sphingolipid C4-monooxygenase.

  • Target Subcellular Location

    Endoplasmic reticulum membrane; Multi-pass membrane protein.

  • Target Protein Families

    Fatty acid desaturase type 1 family, DEGS subfamily

  • Target Tissue Specificity

    Highly expressed in skin, intestine and kidney.

  • Target Synonyms

    DEGS2; C14orf66; Sphingolipid delta(4-desaturase/C4-monooxygenase DES2; Degenerative spermatocyte homolog 2; Sphingolipid 4-desaturase; Sphingolipid C4-monooxygenase

Inquire Recombinant Human Sphingolipid delta (4)-desaturase/C4-hydroxylase DES2 (DEGS2), Truncated Now



AbTriva respects your privacy and protects your personal data in accordance with AbTriva. For more information, please see our data protection statement. *

Notification